← Back to screener

Camp4 Therapeutics Corp CAMP

Rank #2143 · Nasdaq · $0.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
32.3
P/E
-4.0
P/B
-1.66
ROE
41.9%
Op. Margin
-8142.3%
Debt Ratio
-12%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -4.0x, P/B -1.66x. Ranks in the top 96% of the universe.

Profitability ★★☆☆☆
Average

ROE 41.9%. Ranks in the top 54% of the universe.

Safety ★★★★★
Excellent

Debt ratio -12%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★
Excellent

Revenue growth of 86.3% year over year. Ranks in the top 4% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2024$0.0B$-0.1B$-0.0B$-0.1B-14822.6-21
2025$0.0B$-0.1B$-0.1B$-0.1B-8142.3-12

← See the full screener